Search results
1 day ago · by Finance News Network May 10, 2024 05:00 PM. Dr Mark Cooksey - Managing Director & CEO - ABx Group (ASX:ABX) is a uniquely positioned, high-tech Australian company delivering materials for a ...
1 day ago · 10 May 2024 - Alex Hanly - CEO - Lithium Universe (ASX:LU7) is establishing itself as a prominent lithium project builder. The company's flagship Apollo project is located in James Bay in Canada.
1 day ago · Amiodarone is an antiarrhythmic medication used to treat and prevent a number of types of cardiac dysrhythmias. [4] This includes ventricular tachycardia (VT), ventricular fibrillation (VF), and wide complex tachycardia, as well as atrial fibrillation and paroxysmal supraventricular tachycardia. [4] Evidence in cardiac arrest, however, is poor. [5]
4 hours ago · Currently, IASO Bio has obtained INDs for multiple autoimmune diseases, including NMOSD and MG, in both China and the United States, and plans to accelerate the progress of these projects. In terms of BD collaboration in the field of autoimmunity, we entered into a licensing agreement with Cabaletta Bio, a US cell therapy company, in 2022.
1 day ago · Company Presentations. by Finance News Network May 10, 2024 05:10 PM. Email Alerts for: ASX:MYG. Andrew Rowe - Managing Director - Mayfield Group Holdings (ASX:MYG) owns a portfolio of ...
SHANGHAI, NANJING, China, and SAN JOSE, Calif., May 11, 2024 /PRNewswire/ -- *On May 10, 2024, the.. • Press Releases • One News Page: Saturday, 11 May 2024
1 day ago · QINLOCK grew 367% year over year to $6.1 million and NUZYRA increased 81% to $9.9 million for the first quarter of 2024. The growth was supported by the inclusion of QINLOCK and the IV formulation of NUZYRA in the NRDL in the first quarter of 2023, as well as the inclusion of the oral formulation of NUZYRA in the first quarter of 2024.
